Please login to the form below

Not currently logged in
Email:
Password:

EM Imaging appoints new chairman

John Jeans to bring firm to forefront of molecular imaging market
EM Imaging John Jeans

The Board of Edinburgh Molecular Imaging (EM Imaging) has appointed John Jeans as non-executive chairman.

Jeans joins with over 35 years of experience having formerly held leadership positions at Bristol-Myers Squibb, Johnson & Johnson and Amersham.

In 2014, Jeans was appointed by the prime minister as the UK's government life science champion for medical technology and two years prior was awarded CBE for services to healthcare and science.

He said: “The team at Edinburgh Molecular Imaging have made great progress in establishing a strong portfolio of optical imaging opportunities and it's a privilege to be joining the company as it enters this exciting period of further development.”

Ian Wilson, CEO of EM Imaging, said: “With his extensive experience in the healthcare and diagnostics sector John is an extremely valuable addition to the company.

“His deep expertise and leadership skills will be central to supporting EM Imaging in bringing its novel optical imaging technology to the forefront of the global molecular imaging market.”

Jeans also chairs the board of UK Biocentre, and has sat on advisory panels for the MRC, EPSRC, NIHR and the Wellcome Trust. 

7th September 2015

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
COUCH.

WE ARE COUCH – a full service medical communications agency. We are a trusted partner; always striving to help make...

Latest intelligence

Brain power: fresh approaches to Alzheimer’s drug discovery
New alliances are learning from past mistakes and breaking down research barriers...
Genomics integration: can the NHS rise to the challenge?
Experts gather to discuss the UK’s genomic landscape...
London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...

Infographics